Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Breast Neoplasms 45Endometrial Neoplasms 10Triple Negative Breast Neoplasms 4Ovarian Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Progesterone Resistance 2HR+/HER2- Breast Cancer 2HR Positive HER2 Negative Advanced Breast Cancer 2Endometrial Hyperplasia 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Breast Neoplasms, Male 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Peritoneal Neoplasms 1Pathologic Complete Response 1Obesity 1Neoplasms by Site 1Low-Grade Serous Ovarian Cancer 1Low Grade Serous Ovarian Carcinoma 1Low Grade Serous Ovarian Cancer 1Locoregional Recurrence 1Leiomyoma 1Infertility, Female 1Infertility 1

Interventions

Tirzepatide 5semaglutide 2Observation 2Metformin 2Exercise 2Counseling 2mirabegron 1atezolizumab 1Weights and Measures 1Walk Test 1Trehalase 1Therapeutics 1Tablets 1TIC10 compound 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Resistance Training 1Progestins 1Pregabalin 1Population Groups 1Omeprazole 1Nutrition Assessment 1Negative-Pressure Wound Therapy 1Methods 1Metabolic Networks and Pathways 1Liraglutide 1Letrozole 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Ketorolac 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Obesity × Letrozole × Clear all
NCT06379113 2025-08-11

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Fudan University

Phase 2/3 Recruiting
29 enrolled
GynecologicOther

Progesterone Resistance, Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡